Premier Alternatives

Invirsa

Columbus, OH · Founded 2014 · Privately Held (backing)

Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways. Invirsa is based in Columbus, OH and was founded in 2014. Its last reported valuation was $38 million in Nov 2023. It has raised $14.3 million across 3 recorded rounds; the latest was a $2.9 million seed round in Jul 2025.

Last reported valuation
$38.0M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Jul 2025

Invirsa key facts

as of Oct 2026
  • Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways.
  • Invirsa is valued at approximately $38.0M as of Oct 2026 (last reported valuation).
  • It has raised $14.3M across 3 recorded rounds; the latest was Seed Round ($2.9M) in Jul 2025.
  • Notable investors include Endless Frontier Labs, Jumpstart Ventures, JobsOhio Ventures, Rev1 Ventures, CincyTech — 8 tracked in total.
  • Invirsa has filed 5 Form Ds with the SEC since 2020, most recently Aug 2025 ($2.9M sold to 14 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$38.0M

Invirsa's last reported valuation, Nov 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Invirsa with a free account
  • ·Watch Invirsa: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Invirsa funding rounds

3 rounds
Jul 2025Seed Round$2.9MSEC filing▮
Nov 2023Seed Round$1.0MSEC filing▮
Dec 2022Early Stage VC$6.0MSEC filing▮
Full funding history →

Invirsa valuation

Invirsa's last reported valuation was $38 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Invirsa raised?

Invirsa has raised $14.3 million across 3 recorded rounds since 2022. The largest was a $1 million seed round in Nov 2023; the most recent was a $2.9 million seed round in Jul 2025.

Invirsa has filed 5 Form Ds with the SEC since 2020, most recently in Aug 2025 ($2.9 million sold to 14 investors).

Invirsa investors

8 investors are on record for Invirsa, including Endless Frontier Labs, Jumpstart Ventures, JobsOhio Ventures and Rev1 Ventures. The seed round in Jul 2025 drew 14 investors.

About Invirsa

Developer of a therapeutic platform designed to treat infectious and inflammatory eye diseases through activation of innate cellular defense and repair pathways. The company offers a novel approach demonstrating clinical efficacy in diabetic dry eye and infectious conjunctivitis, enabling patients with ocular surface disorders to experience improved healing and reduced disease burden.

Sector
Healthcare
HQ
Columbus, OH, United States
Founded
2014
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.